Instil Bio shares are trading higher. ImmuneOnce Biopharmaceuticals received a $5 million near-term payment from the company's SynBioTx..
Portfolio Pulse from Benzinga Newsdesk
Instil Bio shares are trading higher following news that ImmuneOnce Biopharmaceuticals received a $5 million near-term payment from SynBioTx, a company associated with Instil Bio.
September 11, 2024 | 3:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Instil Bio shares are experiencing an upward trend due to a $5 million payment received by ImmuneOnce Biopharmaceuticals from SynBioTx, which is linked to Instil Bio.
The $5 million payment to ImmuneOnce Biopharmaceuticals, associated with Instil Bio, is likely seen as a positive financial development, boosting investor confidence and driving the stock price higher.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80